OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development
Iwona Radziejewska
Cancers (2023) Vol. 15, Iss. 10, pp. 2680-2680
Open Access | Times Cited: 8

Showing 8 citing articles:

Emerging paradigms and recent progress in targeting ErbB in cancers
Nicolas Stoup, Maxime Liberelle, Nicolas Lebègue, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 552-576
Open Access | Times Cited: 5

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications
Rosalia Dieli, Rosa Lioy, Fabiana Crispo, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 275-275
Open Access

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Wojciech Szymanowski, A. Szymanowska, Anna Bielawska, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5300-5300
Open Access | Times Cited: 11

MUC1 and MUC4 expression are inversely correlated and trigger immunological response and transport pathways in adult-type diffuse gliomas
Gabriel Cardoso Machado, Valéria Pereira Ferrer
Computers in Biology and Medicine (2025) Vol. 187, pp. 109730-109730
Closed Access

MUC1 and MUC4 expression are inversely correlated and trigger immunological response and transport pathways in gliomas
Gabriel Cardoso Machado, Valéria Pereira Ferrer
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Can Galectin-3 Be a Novel Biomarker in Chronic Lymphocytic Leukemia?
Justyna Woś, Agata Szymańska, Natalia Lehman, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 30-30
Open Access | Times Cited: 3

Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells
Iwona Radziejewska, Katarzyna Supruniuk, Katarzyna Jakimiuk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13036-13036
Open Access | Times Cited: 2


Ramanjot Kaur, Shreya Singh Kashyap, Jatinder Singh, et al.
Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences (2024) Vol. 10, Iss. 01
Open Access

Page 1

Scroll to top